Sony acquires flow cytometry maker iCyt
This article was originally published in The Gray Sheet
Executive Summary
Sony Corp. enters the flow cytometry business through the acquisition of iCyt Mission Technology, a Champaign, Ill., producer of flow cytometers and high-performance cell sorters used for stem cell and disease research, firms announce Feb. 9. Sony has been exploring health care applications for its consumer-based optic technologies, and through the acquisition expects to accelerate development of next-generation cell analysis systems. iCyt founder and CEO Gary Durack will continue to lead iCyt as a wholly-owned subsidiary of Sony